After President Trump complained, India reversed its export ban on the anti-malaria drug, which Trump has touted as a coronavirus treatment. There's no clinical evidence it works against COVID-19.
Read more on NPR
Thursday, 9 April 2020
loobobilly News: After Reverse On Hydroxychloroquine Export Ban, India Says 'Only Meeting The Demand'
Labels:
Business
,
loobobillyNPR
After President Trump complained, India reversed its export ban on the anti-malaria drug, which Trump has touted as a coronavirus treatment. There's no clinical evidence it works against COVID-19.
Read more on NPR
Do You Like This Article
Get Subscribe to Free Email Updates!!
Popular Posts
-
Judge to dismiss Sarah Palin lawsuit against 'New York Times' A federal judge will dismiss Sarah Palin's defamation lawsuit agai...
-
Just as China asserts its authority over virtual currencies, other investors in the region are speculating on their value in growing exchang...
-
Researchers are creating tools to find A.I.-generated fake videos before they become impossible to detect. Some experts fear it is a losing ...
-
U.S. Recycling Industry Is Struggling to Figure Out A Future Without China China is no longer taking the world's waste. The U.S. recycli...
-
govnanavernisuka : Realness 29TH SEPTEMBER 2016 REBLOGGED FROM GOVNANAVERNISUKA NOTES: 5163 svetlanak...
-
Government Signs Deal For COVID-19 Treatments From Eli Lilly The federal government plans to distribute 300,000 doses of the drug at no cost...
-
Days Before Election, Tech CEOs Defend Themselves From GOP Claims Of Censorship The chief executives of Facebook, Twitter and Google face sk...
